Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Practical considerations for quantitative clinical SPECT/CT imaging of alpha particle emitting radioisotopes.
Benabdallah N, Scheve W, Dunn N, Silvestros D, Schelker P, Abou D, Jammalamadaka U, Laforest R, Li Z, Liu J, Ballard DH, Maughan NM, Gay H, Baumann BC, Hobbs RF, Rogers B, Iravani A, Jha AK, Dehdashti F, Thorek DLJ. Benabdallah N, et al. Among authors: baumann bc. Theranostics. 2021 Sep 27;11(20):9721-9737. doi: 10.7150/thno.63860. eCollection 2021. Theranostics. 2021. PMID: 34815780 Free PMC article.
Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital-based analysis of patterns of care, RT fractionation scheme, and overall survival.
Fischer-Valuck BW, Baumann BC, Apicelli A, Rao YJ, Roach M, Daly M, Dans MC, White P, Contreras J, Henke L, Gay H, Michalski JM, Abraham C. Fischer-Valuck BW, et al. Among authors: baumann bc. Cancer Med. 2018 Sep;7(9):4240-4250. doi: 10.1002/cam4.1655. Epub 2018 Aug 17. Cancer Med. 2018. PMID: 30120817 Free PMC article.
Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/RTOG 0526).
Brenneman RJ, Soffen E, Gay HA, Orio PF 3rd, Christodouleas JP, Baumann JC, Baumann BC. Brenneman RJ, et al. Among authors: baumann bc, baumann jc. Transl Androl Urol. 2019 Jul;8(Suppl 3):S265-S270. doi: 10.21037/tau.2019.03.14. Transl Androl Urol. 2019. PMID: 31392141 Free PMC article. No abstract available.
Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience.
Barnes JM, Gabani P, Sanders M, Chundury A, Altman M, Garcia-Ramirez J, Li H, Zoberi JE, Baumann BC, Gay HA. Barnes JM, et al. Among authors: baumann bc. J Contemp Brachytherapy. 2019 Oct;11(5):399-408. doi: 10.5114/jcb.2019.89367. Epub 2019 Oct 30. J Contemp Brachytherapy. 2019. PMID: 31749847 Free PMC article.
126 results